NEUNEUREN PHARMACEUTICALS LIMITEDMarket sensitive

First site initiated for Neuren's PMS Phase 3 trial

Date and time
Announcement type
Company Update

More from Health Care

RGTCompany Update29 September 2026

Argent BioPharma (ASX: RGT) Licences NLC Antiviral Portfolio

More News